Interconnected PCL Scaffolds for Therapeutic Cell Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cellular therapeutics face challenges in effectively delivering therapeutic cells to treat diseases due to limitations in scaffold design and integration with host tissues, particularly for conditions like diabetes and cancer.
Innovation Solution
The development of polycaprolactone (PCL) scaffolds with interconnected macropores and micropores, which facilitate the encapsulation of therapeutic cells, such as insulin-secreting cells and lymphocytes, to create tissue grafts that can be implanted at physiological sites, promoting vascularization and maintaining cell functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional small molecule or biologic therapies are used, then treatment delivery is straightforward, but they cannot effectively treat diseases requiring cellular therapeutics
Solution Approach 1:
The patent employs a porous scaffold structure with interconnected pores to encapsulate and deliver therapeutic cells. The porous architecture allows cells to be retained within the scaffold while permitting nutrient diffusion and waste removal, enabling effective cellular therapeutics delivery that cannot be achieved with conventional small molecule or biologic therapies alone.
Solution Approach 2:
The invention combines biocompatible polymer materials with therapeutic cells to create a composite tissue graft system. This composite structure integrates the mechanical support and protective functions of the polymer scaffold with the therapeutic functions of the encapsulated cells, achieving treatment effectiveness that neither component could provide alone.
2Reliability
If therapeutic cells are transplanted without proper scaffold support, then transplantation is simple, but cell functionality and integration with host tissues are compromised
Solution Approach 1:
The porous scaffold provides a three-dimensional structure that mimics the natural extracellular matrix, supporting cell attachment, proliferation, and maintenance of functionality. The interconnected pores allow for nutrient transport and waste removal while retaining cells within the graft, ensuring long-term cell viability and function.
Solution Approach 2:
The scaffold acts as an intermediary between the transplanted cells and the host tissue environment. It provides mechanical support, protects cells during transplantation, facilitates integration with host tissues through vascular ingrowth, and maintains the microenvironment necessary for cell functionality.
3Quantity of substance
If macropores are enlarged to accommodate cell aggregates, then cell encapsulation capacity increases, but structural integrity of the scaffold may be compromised
Solution Approach 1:
The scaffold exhibits local quality variations with different pore sizes distributed throughout the structure. Macropores are strategically positioned and sized to accommodate cell aggregates while maintaining overall structural integrity. The micropore network provides additional structural support and maintains mechanical strength even with enlarged macropores.
Solution Approach 2:
The pore structure is segmented into two distinct levels: macropores for cell aggregate accommodation and micropores for structural support and nutrient transport. This segmentation allows the scaffold to simultaneously provide large spaces for cell encapsulation while maintaining mechanical integrity through the finer micropore network.
4Reliability
If scaffold porosity is increased to facilitate cell infiltration and nutrient transport, then cell viability improves, but mechanical strength of the scaffold decreases
Solution Approach 1:
The porous structure is segmented into macropores and micropores with different functions. Macropores facilitate cell infiltration and nutrient transport to improve cell viability, while the interconnected micropore network provides structural support to maintain mechanical strength. This hierarchical segmentation resolves the trade-off between porosity and strength.
Solution Approach 2:
The scaffold utilizes a controlled porous architecture where pore size, distribution, and interconnectivity are optimized to balance mechanical strength and biological functionality. The porous structure allows sufficient nutrient transport and cell infiltration while maintaining adequate mechanical properties for surgical handling and implantation.
Data Source
AI summary
Polycaprolactone (PCL) scaffolds having macropores interconnected with micorpores are provided. Tissue grafts that include the PCL scaffold having therapeutic cells encapsulated within the macropores are also provided. Also provided are methods of making the PCL scaffold and the tissue graft, and methods of transplanting cells into an individual using the tissue graft.